Eli Lilly and Company (LLY MU) stock market data APIs
€876.8238
0(0%)
as of February 17, 2026
Try our APIs with
free plan!
Eli Lilly and Company Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for LLY.MU.
Prev. Close
876.8238
Open
876.8238
High
876.8238
Low
876.8238
52 wk Range
535.2574-959.766
Market Cap
206 794 M
Dividends (Yield)
0.0148
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Eli Lilly and Company data using free add-ons & libraries
Get Eli Lilly and Company Fundamental Data
Eli Lilly and Company Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-04
- EPS/Forecast: 6.93
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Eli Lilly and Company News
New
Eli Lilly Advances Gene Editing And Lung Cancer Programs With Valuation Upside
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Eli Lilly (NYSE:LLY) reached a second milestone in its CR...
Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk
Hims stock landed in hot water this month after Novo Nordisk slammed the telehealth giant with a lawsuit over its knockoff obesity drug. Continue Reading
Eli Lilly Stock Rises as $1.5 Billion Weight-Loss Pill Prepares to Hit Market
This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY) climbed about 0.5% in premarket trading Tuesday as the company builds roughly $1.5 billion in inventory for its upcoming oral weight-los...
AbbVie Down Since Q4 Earnings Report: How to Play the Stock
AbbVie (ABBV) stock felt some downward pressure despite reporting better-than-expected fourth-quarter results on Feb. 4. AbbVie beat estimates for both earnings and sales and also issued an upbeat ou...
Get Eli Lilly and Company fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
